// App-Quantinova.ai

: Targeting an RNaseH2 Defect in Chronic Lymphocytic Leukaemia with PARP Inhibitors

Researchers

Presenter

  • Angelo Agathaggelou

Principal Investigators

  • Olga Murina

  • Andrew P Jackson

  • Paul Moss

  • Shankara Paneesha

  • Grant S Stewart

  • Malcolm Taylor

  • Tatjana Stankovic

Medical Centers

  • University of Birmingham, Birmingham, United Kingdom

  • Birmingham Children's Hospital, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Talazoparib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved